300434.SZ
Sichuan Goldstone Asia Pharmaceutical, Inc.
SZSE · Industrials · C 制造业 · CN
CNY 11.27
−4.81%Margins
Gross margin
59.7%
EBITDA margin
23.8%
EBIT margin
19.4%
Net margin
17.1%
FCF margin
10.3%
6.9%
Return on equity
5.8%
Return on assets
7.7%
Return on invested capital
0.34x
Asset turnover
CNY 193.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026